Fig. 2From: Demethylation of HIN-1 reverses paclitaxel-resistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathwaya Caspase-3/7 activity in both ES2 and ESTR160 cells with or without paclitaxel treatment. The expression levels of (b) MDR1, (c) NANOG, HIF-1α, HIF-2α, and Snai2, (d) TWIST1, and (e) ABCG2 in ES2 and TOV21G parental cells and their derived paclitaxel-resistant ES2TR160 and TOV21GTR200 cells by QRT-PCRBack to article page